- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04282057
Effects of Shockwave Therapy Versus Radiofrequency
Effect of an Aerobic Exercise Program Associated With Shock Wave Therapy Versus Radiofrequency on Skin and Subcutaneous Tissue: Randomized Controlled Study
Study Overview
Status
Intervention / Treatment
Detailed Description
With the increasing awareness of the population regarding the high rate of obesity and the number of deaths per year as a result of being overweight, treatments for reducing measures are increasingly sought.
The evidence shows that the accumulation of fat located in the abdominal region is a risk factor for dyslipidemia and arterial hypertension, and a reduction in waist circumference can reduce the potential risk of cardiovascular disease.
In addition to this concern, with the aging of the population and changes in body dimensions due to pregnancy or to a weight loss process, body flaccidity is also a growing cosmetic complaint, and the result is a less firm and pending skin.
Physical exercise is a very important agent for combating excess weight, with special attention to aerobic physical exercise, which is able to decrease body fat tissue and increase the oxidation of fatty acids by 5 to 10 times more than in resting state. The evidence points out that the exercise prescription to decrease fat mass should focus on a high volume of training (30 to 60 minutes) with moderate intensity (40 to 60% of Heart Rate Reserve), performed regularly and mobilizing large muscle groups.
In order to combat abdominal adiposity, as well as the flaccidity of the region, radiofrequency is presented as a possible complementary strategy.
Radiofrequency is an electromagnetic wave that when applied to skin, generates oscillating magnetic fields that move electrically charged particles producing heat in the tissues. The amount of heat produced is dependent on resistance.
Shock wave therapy consists of the application of high energy acoustic waves whose main characteristic is the production of a high pressure pulse induced in a short period of time. This will generate mechanical pressure waves in the tissues, promoting cavitation, with the formation of gas bubbles in the intervening fluids and an increase in local temperature.
The main objective of this study is to compare the effect of 6 sessions of shock wave therapy versus radiofrequency followed by a protocol of moderate aerobic exercise, in the reduction of adiposity and abdominal flaccidity, in females between 18 and 60 years old. As a secondary objective, it is intended to understand the mechanism of fat mobilization by these two therapies.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Porto
-
Vila Nova de Gaia, Porto, Portugal, 4400-330
- Andreia Noites
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Women aged 18 to 60 years
Exclusion Criteria:
- smoking and drinking habits;
- athletes;
- people with dietary restrictions;
- participants who have had diets to lose weight in the last 3 months or who will start during the study;
- pregnant women;
- in postpartum less than one year;
- breastfeeding;
- intending to become pregnant during the study period;
- patients with electronic or metallic devices (pacemaker, IUD);
- individuals with metabolic (including dyslipidemias);
- hematological and renal disorders;
- individuals with dermatological changes;
- cardiovascular, respiratory, digestive, orthopedic, rheumatological and oncological pathologies;
- changes in the immune system or with acute inflammatory processes;
- changes in sensitivity or subject to medication (anti-coagulants, corticosteroids up to 6 weeks before, non-steroidal anti-inflammatory drugs, antihistamines, diuretics)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: shockwave therapy group
This group performed aerobic exercise just after shock wave therapy in the abdominal region.
|
The shock wave device corresponds to the BTL-6000 X-Wave TM with a 20mm transmitter multifocal.
The parameters used correspond to the pressure set between 2.8 and 3.5 bar, frequency 15 hertz and 3000 pulses per 10x15 cm area.
It was used as a means contact gel for ultrasound, reference 033-051.
In this procedure the participants found themselves in the supine position, with a pillow under the head and with the bending knees.
|
|
EXPERIMENTAL: radiofrequency group
This group performed aerobic exercise just after radiofrequency in the abdominal region.
|
Radiofrequency protocol - The radiofrequency protocol was performed in dorsal decubitus, with the head elevated at 45 degrees.
The application was in capacitive mode, with a 7cm electrode, always in movement.
The duration of the application was established in 15 minutes, maintaining the local temperature between 40 to 42 celsius degrees at the epidermis.
|
|
ACTIVE_COMPARATOR: control group
This group only performed aerobic exercise.
|
Aerobic exercise protocol - 40 minutes of aerobic moderate-intensity exercise (45-55% of reserve heart rate) using Karvonen's formula, performed on a cycloergometer.
The duration of the exercise was divided into three parts: warm-up (5 minutes); body (30 minutes); and cooling (from 5 to 10 minutes).
The entire protocol was monitored through the Polar® brand heart rate monitor and watch.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cutaneous abdominal tissue thickness
Time Frame: Baseline
|
Measurement of the cutaneous fold by ultrasonography
|
Baseline
|
|
Cutaneous abdominal tissue thickness
Time Frame: 3 weeks after
|
Measurement of the cutaneous fold by ultrasonography
|
3 weeks after
|
|
Cutaneous abdominal tissue thickness
Time Frame: 6 weeks after
|
Measurement of the cutaneous fold by ultrasonography
|
6 weeks after
|
|
Subcutaneous abdominal tissue thickness
Time Frame: Baseline
|
Measurement of the subcutaneous adipose fold by ultrasonography
|
Baseline
|
|
Subcutaneous abdominal tissue thickness
Time Frame: 3 weeks after
|
Measurement of the subcutaneous adipose fold by ultrasonography
|
3 weeks after
|
|
Subcutaneous abdominal tissue thickness
Time Frame: 6 weeks after
|
Measurement of the subcutaneous adipose fold by ultrasonography
|
6 weeks after
|
|
Glycerol concentration
Time Frame: Baseline
|
Blood analysis collection carried out with help from an clinical analysis technician
|
Baseline
|
|
Glycerol concentration
Time Frame: 3 weeks after
|
Blood analysis collection carried out with help from an clinical analysis technician
|
3 weeks after
|
|
Glycerol concentration
Time Frame: 6 weeks after
|
Blood analysis collection carried out with help from an clinical analysis technician
|
6 weeks after
|
|
Lipid profile (LDL, HDL and triglyceride concentrations)
Time Frame: Baseline
|
Blood analysis collection carried out with help from an clinical analysis technician
|
Baseline
|
|
Lipid profile (LDL, HDL and triglyceride concentrations)
Time Frame: 3 weeks after
|
Blood analysis collection carried out with help from an clinical analysis technician
|
3 weeks after
|
|
Lipid profile (LDL, HDL and triglyceride concentrations)
Time Frame: 6 weeks after
|
Blood analysis collection carried out with help from an clinical analysis technician
|
6 weeks after
|
|
Perimetry
Time Frame: Baseline
|
Perimetry consists of measuring circumferences.
In this case, of the waist at the navel area, 3 cm below it and in the hip area
|
Baseline
|
|
Perimetry
Time Frame: 3 weeks after
|
Perimetry consists of measuring circumferences.
In this case, of the waist at the navel area, 3 cm below it and in the hip area
|
3 weeks after
|
|
Perimetry
Time Frame: 6 weeks after
|
Perimetry consists of measuring circumferences.
In this case, of the waist at the navel area, 3 cm below it and in the hip area
|
6 weeks after
|
|
Adipometry
Time Frame: Baseline
|
Adipometry consists of measuring skinfold thickness
|
Baseline
|
|
Adipometry
Time Frame: 3 weeks after
|
Adipometry consists of measuring skinfold thickness
|
3 weeks after
|
|
Adipometry
Time Frame: 6 weeks after
|
Adipometry consists of measuring skinfold thickness
|
6 weeks after
|
|
Inflammatory markers concentration (IL6, CRP, TNF)
Time Frame: Baseline
|
Blood analysis collection carried out with help from an clinical analysis technician
|
Baseline
|
|
Inflammatory markers concentration (IL6, CRP, TNF)
Time Frame: 3 weeks after
|
Blood analysis collection carried out with help from an clinical analysis technician
|
3 weeks after
|
|
Inflammatory markers concentration (IL6, CRP, TNF)
Time Frame: 6 weeks after
|
Blood analysis collection carried out with help from an clinical analysis technician
|
6 weeks after
|
|
Nitrous oxide concentration
Time Frame: Baseline
|
Blood analysis collection carried out with help from an clinical analysis technician
|
Baseline
|
|
Nitrous oxide concentration
Time Frame: 3 weeks after
|
Blood analysis collection carried out with help from an clinical analysis technician
|
3 weeks after
|
|
Nitrous oxide concentration
Time Frame: 6 weeks after
|
Blood analysis collection carried out with help from an clinical analysis technician
|
6 weeks after
|
|
Body composition- body mass
Time Frame: Baseline
|
body mass in kilograms
|
Baseline
|
|
Body composition- body mass
Time Frame: 3 weeks after
|
body mass in kilograms
|
3 weeks after
|
|
Body composition- body mass
Time Frame: 6 weeks after
|
body mass in kilograms
|
6 weeks after
|
|
Body composition- muscle mass
Time Frame: Baseline
|
muscle mass in kilograms
|
Baseline
|
|
Body composition- muscle mass
Time Frame: 3 weeks after
|
muscle mass in kilograms
|
3 weeks after
|
|
Body composition- muscle mass
Time Frame: 6 weeks after
|
muscle mass in kilograms
|
6 weeks after
|
|
Body composition- fat mass
Time Frame: Baseline
|
fat mass in kilograms
|
Baseline
|
|
Body composition- fat mass
Time Frame: 3 weeks after
|
fat mass in kilograms
|
3 weeks after
|
|
Body composition- fat mass
Time Frame: 6 weeks after
|
fat mass in kilograms
|
6 weeks after
|
|
Body composition- visceral fat
Time Frame: Baseline
|
visceral fat
|
Baseline
|
|
Body composition- visceral fat
Time Frame: 3 weeks after
|
visceral fat
|
3 weeks after
|
|
Body composition- visceral fat
Time Frame: 6 weeks after
|
visceral fat
|
6 weeks after
|
|
Body composition- fat body areas
Time Frame: Baseline
|
percentage of fat distributed by body areas
|
Baseline
|
|
Body composition- fat body areas
Time Frame: 3 weeks after
|
percentage of fat distributed by body areas
|
3 weeks after
|
|
Body composition- fat body areas
Time Frame: 6 weeks after
|
percentage of fat distributed by body areas
|
6 weeks after
|
|
Thermography
Time Frame: Baseline
|
Thermography is used to assess the temperature of the skin surface, and it is also possible to suppose changes in blood flow and vascularization with this outcome
|
Baseline
|
|
Thermography
Time Frame: 3 weeks after
|
Thermography is used to assess the temperature of the skin surface, and it is also possible to suppose changes in blood flow and vascularization with this outcome
|
3 weeks after
|
|
Thermography
Time Frame: 6 weeks after
|
Thermography is used to assess the temperature of the skin surface, and it is also possible to suppose changes in blood flow and vascularization with this outcome
|
6 weeks after
|
|
Photography
Time Frame: Baseline
|
Photography is used to compare the before and after images.
With these it is possible to evaluate the skin flaccidity and fat
|
Baseline
|
|
Photography
Time Frame: 3 weeks after
|
Photography is used to compare the before and after images.
With these it is possible to evaluate the skin flaccidity and fat
|
3 weeks after
|
|
Photography
Time Frame: 6 weeks after
|
Photography is used to compare the before and after images.
With these it is possible to evaluate the skin flaccidity and fat
|
6 weeks after
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
skin flaccidity
Time Frame: Baseline
|
Investigator Assessment Skin Laxity Scoring System - Questionnaire that evaluates skin flaccidity and scores from 0 to 4. (As the subjectivity assessment of this outcome, the investigator who evaluates is blind to the group that the participants are allocated, in order to avoid partial scores)
|
Baseline
|
|
skin flaccidity
Time Frame: 3 weeks after
|
Investigator Assessment Skin Laxity Scoring System - Questionnaire that evaluates skin flaccidity and scores from 0 to 4. (As the subjectivity assessment of this outcome, the investigator who evaluates is blind to the group that the participants are allocated, in order to avoid partial scores)
|
3 weeks after
|
|
skin flaccidity
Time Frame: 6 weeks after
|
Investigator Assessment Skin Laxity Scoring System - Questionnaire that evaluates skin flaccidity and scores from 0 to 4. (As the subjectivity assessment of this outcome, the investigator who evaluates is blind to the group that the participants are allocated, in order to avoid partial scores)
|
6 weeks after
|
|
skin flaccidity and localized fat in the abdomen region
Time Frame: Baseline
|
Satisfaction questionnaire to evaluate the final results according to the participant
|
Baseline
|
|
skin flaccidity and localized fat in the abdomen region
Time Frame: 3 weeks after
|
Satisfaction questionnaire to evaluate the final results according to the participant
|
3 weeks after
|
|
skin flaccidity and localized fat in the abdomen region
Time Frame: 6 weeks after
|
Satisfaction questionnaire to evaluate the final results according to the participant
|
6 weeks after
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Adatto MA, Adatto-Neilson R, Novak P, Krotz A, Haller G. Body shaping with acoustic wave therapy AWT((R))/EPAT((R)): randomized, controlled study on 14 subjects. J Cosmet Laser Ther. 2011 Dec;13(6):291-6. doi: 10.3109/14764172.2011.630089.
- Modena DAO, da Silva CN, Grecco C, Guidi RM, Moreira RG, Coelho AA, Sant'Ana E, de Souza JR. Extracorporeal shockwave: mechanisms of action and physiological aspects for cellulite, body shaping, and localized fat-Systematic review. J Cosmet Laser Ther. 2017 Oct;19(6):314-319. doi: 10.1080/14764172.2017.1334928. Epub 2017 Jun 7.
- Noites A, Vale AL, Pereira AS, Morais A, Vilarinho R, Carvalho P, Amorim M, Moreira T, Mendonca A. Effect of an aerobic exercise session combined with abdominal radiofrequency on lipolytic activity in women: Randomized control trial. J Cosmet Dermatol. 2020 Mar;19(3):638-645. doi: 10.1111/jocd.13056. Epub 2019 Jun 29.
- Vale AL, Pereira AS, Morais A, de Carvalho P, Vilarinho R, Mendonca A, Noites A. Effect of four sessions of aerobic exercise with abdominal radiofrequency in adipose tissue in healthy women: Randomized control trial. J Cosmet Dermatol. 2020 Feb;19(2):359-367. doi: 10.1111/jocd.13036. Epub 2019 Jun 3.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AN-009
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Risk Factor
-
University of Southern DenmarkRegion of Southern Denmark; Odense Patient Data Explorative Network; ENIGMA Solutions... and other collaboratorsActive, not recruitingCardiovascular Risk Factor | Risk CommunicationDenmark
-
University of Split, School of MedicineCompletedCardiovascular Risk Factor | Lifestyle Risk ReductionCroatia
-
University Hospital, BrestRecruiting
-
University Hospitals Cleveland Medical CenterRecruitingCardiovascular Risk FactorUnited States
-
Northwestern UniversityCase Western Reserve University; Shirley Ryan AbilityLab; Skokie Health Department and other collaboratorsCompleted
-
University of ArizonaTerminatedCardiovascular Risk FactorUnited States
-
Penn State UniversityCompletedCardiovascular Risk FactorUnited States
-
Clinique BizetCompleted
-
University Hospital, BrestCompleted
-
University of DelawareCompleted
Clinical Trials on Shock wave therapy
-
Rodrigo Marcel Valentim da SilvaUniversidade Federal do Rio Grande do NorteCompletedPain | Muscle Tonus
-
Northern Orthopaedic Division, DenmarkCompletedChronic Inflammatory Disorder
-
University Hospital St. PoltenNot yet recruiting
-
Yuzuncu Yıl UniversityCompleted
-
Isfahan University of Medical SciencesUnknownPlantar FasciitisIran, Islamic Republic of
-
Yonsei UniversityUnknownPost-Stroke Elbow SpasticityKorea, Republic of
-
KMUHIRB-F(I)-20230051RecruitingMetabolic Syndrome | Urgency-Frequency | Bladder, Overactive | Lower Urinary Track Symptoms | BladderTaiwan
-
Carol Davila University of Medicine and PharmacyCompletedStroke, Ischemic | Stroke Hemorrhagic | Balance; Distorted | Spasticity as Sequela of Stroke | Spastic GaitRomania
-
Oslo University HospitalUnknownShoulder Impingement Syndrome | Subacromial Shoulder PainNorway
-
ZHANG PENGZhongda HospitalNot yet recruitingLateral Epicondylitis (Tennis Elbow)China